Click for best price
Ophthalmic Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 31890 million
|
Forecast Market size by 2030 |
US$ 55200 million
|
| Growth Rate |
CAGR of 8.2% |
Number of Pages |
117 Pages |
This research report provides a comprehensive analysis of the Ophthalmic Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Ophthalmic Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Ophthalmic Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Ophthalmic Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Ophthalmic Drugs market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Ophthalmic Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Ophthalmic Drugs market was valued at US$ 31890 million in 2023 and is projected to reach US$ 55200 million by 2030, at a CAGR of 8.2% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Ophthalmic Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Ophthalmic Drugs market.
Market Overview: The report provides a comprehensive overview of the Ophthalmic Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Anti-allergy, Anti-VEGF Agents), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Ophthalmic Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Ophthalmic Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Ophthalmic Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Ophthalmic Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Ophthalmic Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Ophthalmic Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Ophthalmic Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Ophthalmic Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Ophthalmic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Anti-allergy
- Anti-VEGF Agents
- Anti-inflammatory
- Anti-glaucoma
Market segment by Application
Global Ophthalmic Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Santen Pharmaceutical
- Bausch Health
- Takeda
- Novartis
- Genentech
- Allergan
- Sun Pharmaceutical Industries
- Actavis Generics
- Regeneron Pharmaceuticals
- Pfizer
- Johnson and Johnson
- Bausch and Lomb
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Drugs, market overview.
Chapter 2: Global Ophthalmic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Ophthalmic Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 31890 million
|
| Forecast Market size by 2030 |
US$ 55200 million
|
| Growth Rate |
CAGR of 8.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
117 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ophthalmic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmic Drugs Overall Market Size
2.1 Global Ophthalmic Drugs Market Size: 2023 VS 2030
2.2 Global Ophthalmic Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Ophthalmic Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Ophthalmic Drugs Players in Global Market
3.2 Top Global Ophthalmic Drugs Companies Ranked by Revenue
3.3 Global Ophthalmic Drugs Revenue by Companies
3.4 Global Ophthalmic Drugs Sales by Companies
3.5 Global Ophthalmic Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Ophthalmic Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Ophthalmic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ophthalmic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Ophthalmic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Ophthalmic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Ophthalmic Drugs Market Size Markets, 2023 & 2030
4.1.2 Anti-allergy
4.1.3 Anti-VEGF Agents
4.1.4 Anti-inflammatory
4.1.5 Anti-glaucoma
4.2 By Type - Global Ophthalmic Drugs Revenue & Forecasts
4.2.1 By Type - Global Ophthalmic Drugs Revenue, 2019-2024
4.2.2 By Type - Global Ophthalmic Drugs Revenue, 2025-2030
4.2.3 By Type - Global Ophthalmic Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Ophthalmic Drugs Sales & Forecasts
4.3.1 By Type - Global Ophthalmic Drugs Sales, 2019-2024
4.3.2 By Type - Global Ophthalmic Drugs Sales, 2025-2030
4.3.3 By Type - Global Ophthalmic Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Ophthalmic Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ophthalmic Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacy
5.2 By Application - Global Ophthalmic Drugs Revenue & Forecasts
5.2.1 By Application - Global Ophthalmic Drugs Revenue, 2019-2024
5.2.2 By Application - Global Ophthalmic Drugs Revenue, 2025-2030
5.2.3 By Application - Global Ophthalmic Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Ophthalmic Drugs Sales & Forecasts
5.3.1 By Application - Global Ophthalmic Drugs Sales, 2019-2024
5.3.2 By Application - Global Ophthalmic Drugs Sales, 2025-2030
5.3.3 By Application - Global Ophthalmic Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Ophthalmic Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Ophthalmic Drugs Market Size, 2023 & 2030
6.2 By Region - Global Ophthalmic Drugs Revenue & Forecasts
6.2.1 By Region - Global Ophthalmic Drugs Revenue, 2019-2024
6.2.2 By Region - Global Ophthalmic Drugs Revenue, 2025-2030
6.2.3 By Region - Global Ophthalmic Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Ophthalmic Drugs Sales & Forecasts
6.3.1 By Region - Global Ophthalmic Drugs Sales, 2019-2024
6.3.2 By Region - Global Ophthalmic Drugs Sales, 2025-2030
6.3.3 By Region - Global Ophthalmic Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Ophthalmic Drugs Revenue, 2019-2030
6.4.2 By Country - North America Ophthalmic Drugs Sales, 2019-2030
6.4.3 US Ophthalmic Drugs Market Size, 2019-2030
6.4.4 Canada Ophthalmic Drugs Market Size, 2019-2030
6.4.5 Mexico Ophthalmic Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Ophthalmic Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Ophthalmic Drugs Sales, 2019-2030
6.5.3 Germany Ophthalmic Drugs Market Size, 2019-2030
6.5.4 France Ophthalmic Drugs Market Size, 2019-2030
6.5.5 U.K. Ophthalmic Drugs Market Size, 2019-2030
6.5.6 Italy Ophthalmic Drugs Market Size, 2019-2030
6.5.7 Russia Ophthalmic Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Ophthalmic Drugs Market Size, 2019-2030
6.5.9 Benelux Ophthalmic Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Ophthalmic Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Ophthalmic Drugs Sales, 2019-2030
6.6.3 China Ophthalmic Drugs Market Size, 2019-2030
6.6.4 Japan Ophthalmic Drugs Market Size, 2019-2030
6.6.5 South Korea Ophthalmic Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Ophthalmic Drugs Market Size, 2019-2030
6.6.7 India Ophthalmic Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Ophthalmic Drugs Revenue, 2019-2030
6.7.2 By Country - South America Ophthalmic Drugs Sales, 2019-2030
6.7.3 Brazil Ophthalmic Drugs Market Size, 2019-2030
6.7.4 Argentina Ophthalmic Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ophthalmic Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Ophthalmic Drugs Sales, 2019-2030
6.8.3 Turkey Ophthalmic Drugs Market Size, 2019-2030
6.8.4 Israel Ophthalmic Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Ophthalmic Drugs Market Size, 2019-2030
6.8.6 UAE Ophthalmic Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Santen Pharmaceutical
7.1.1 Santen Pharmaceutical Company Summary
7.1.2 Santen Pharmaceutical Business Overview
7.1.3 Santen Pharmaceutical Ophthalmic Drugs Major Product Offerings
7.1.4 Santen Pharmaceutical Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Santen Pharmaceutical Key News & Latest Developments
7.2 Bausch Health
7.2.1 Bausch Health Company Summary
7.2.2 Bausch Health Business Overview
7.2.3 Bausch Health Ophthalmic Drugs Major Product Offerings
7.2.4 Bausch Health Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Bausch Health Key News & Latest Developments
7.3 Takeda
7.3.1 Takeda Company Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Ophthalmic Drugs Major Product Offerings
7.3.4 Takeda Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Takeda Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Ophthalmic Drugs Major Product Offerings
7.4.4 Novartis Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Novartis Key News & Latest Developments
7.5 Genentech
7.5.1 Genentech Company Summary
7.5.2 Genentech Business Overview
7.5.3 Genentech Ophthalmic Drugs Major Product Offerings
7.5.4 Genentech Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Genentech Key News & Latest Developments
7.6 Allergan
7.6.1 Allergan Company Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Ophthalmic Drugs Major Product Offerings
7.6.4 Allergan Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Allergan Key News & Latest Developments
7.7 Sun Pharmaceutical Industries
7.7.1 Sun Pharmaceutical Industries Company Summary
7.7.2 Sun Pharmaceutical Industries Business Overview
7.7.3 Sun Pharmaceutical Industries Ophthalmic Drugs Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.8 Actavis Generics
7.8.1 Actavis Generics Company Summary
7.8.2 Actavis Generics Business Overview
7.8.3 Actavis Generics Ophthalmic Drugs Major Product Offerings
7.8.4 Actavis Generics Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Actavis Generics Key News & Latest Developments
7.9 Regeneron Pharmaceuticals
7.9.1 Regeneron Pharmaceuticals Company Summary
7.9.2 Regeneron Pharmaceuticals Business Overview
7.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Major Product Offerings
7.9.4 Regeneron Pharmaceuticals Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Ophthalmic Drugs Major Product Offerings
7.10.4 Pfizer Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Pfizer Key News & Latest Developments
7.11 Johnson and Johnson
7.11.1 Johnson and Johnson Company Summary
7.11.2 Johnson and Johnson Business Overview
7.11.3 Johnson and Johnson Ophthalmic Drugs Major Product Offerings
7.11.4 Johnson and Johnson Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Johnson and Johnson Key News & Latest Developments
7.12 Bausch and Lomb
7.12.1 Bausch and Lomb Company Summary
7.12.2 Bausch and Lomb Business Overview
7.12.3 Bausch and Lomb Ophthalmic Drugs Major Product Offerings
7.12.4 Bausch and Lomb Ophthalmic Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Bausch and Lomb Key News & Latest Developments
8 Global Ophthalmic Drugs Production Capacity, Analysis
8.1 Global Ophthalmic Drugs Production Capacity, 2019-2030
8.2 Ophthalmic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Ophthalmic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ophthalmic Drugs Supply Chain Analysis
10.1 Ophthalmic Drugs Industry Value Chain
10.2 Ophthalmic Drugs Upstream Market
10.3 Ophthalmic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ophthalmic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Ophthalmic Drugs in Global Market
Table 2. Top Ophthalmic Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Ophthalmic Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Ophthalmic Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Ophthalmic Drugs Sales by Companies, (K MT), 2019-2024
Table 6. Global Ophthalmic Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Ophthalmic Drugs Price (2019-2024) & (USD/MT)
Table 8. Global Manufacturers Ophthalmic Drugs Product Type
Table 9. List of Global Tier 1 Ophthalmic Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmic Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Ophthalmic Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Ophthalmic Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Ophthalmic Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Ophthalmic Drugs Sales (K MT), 2019-2024
Table 15. By Type - Global Ophthalmic Drugs Sales (K MT), 2025-2030
Table 16. By Application ? Global Ophthalmic Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Ophthalmic Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Ophthalmic Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Ophthalmic Drugs Sales (K MT), 2019-2024
Table 20. By Application - Global Ophthalmic Drugs Sales (K MT), 2025-2030
Table 21. By Region ? Global Ophthalmic Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Ophthalmic Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Ophthalmic Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Ophthalmic Drugs Sales (K MT), 2019-2024
Table 25. By Region - Global Ophthalmic Drugs Sales (K MT), 2025-2030
Table 26. By Country - North America Ophthalmic Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Ophthalmic Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Ophthalmic Drugs Sales, (K MT), 2019-2024
Table 29. By Country - North America Ophthalmic Drugs Sales, (K MT), 2025-2030
Table 30. By Country - Europe Ophthalmic Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Ophthalmic Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Ophthalmic Drugs Sales, (K MT), 2019-2024
Table 33. By Country - Europe Ophthalmic Drugs Sales, (K MT), 2025-2030
Table 34. By Region - Asia Ophthalmic Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Ophthalmic Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Ophthalmic Drugs Sales, (K MT), 2019-2024
Table 37. By Region - Asia Ophthalmic Drugs Sales, (K MT), 2025-2030
Table 38. By Country - South America Ophthalmic Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Ophthalmic Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Ophthalmic Drugs Sales, (K MT), 2019-2024
Table 41. By Country - South America Ophthalmic Drugs Sales, (K MT), 2025-2030
Table 42. By Country - Middle East & Africa Ophthalmic Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Ophthalmic Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Ophthalmic Drugs Sales, (K MT), 2019-2024
Table 45. By Country - Middle East & Africa Ophthalmic Drugs Sales, (K MT), 2025-2030
Table 46. Santen Pharmaceutical Company Summary
Table 47. Santen Pharmaceutical Ophthalmic Drugs Product Offerings
Table 48. Santen Pharmaceutical Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 49. Santen Pharmaceutical Key News & Latest Developments
Table 50. Bausch Health Company Summary
Table 51. Bausch Health Ophthalmic Drugs Product Offerings
Table 52. Bausch Health Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 53. Bausch Health Key News & Latest Developments
Table 54. Takeda Company Summary
Table 55. Takeda Ophthalmic Drugs Product Offerings
Table 56. Takeda Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 57. Takeda Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Ophthalmic Drugs Product Offerings
Table 60. Novartis Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 61. Novartis Key News & Latest Developments
Table 62. Genentech Company Summary
Table 63. Genentech Ophthalmic Drugs Product Offerings
Table 64. Genentech Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 65. Genentech Key News & Latest Developments
Table 66. Allergan Company Summary
Table 67. Allergan Ophthalmic Drugs Product Offerings
Table 68. Allergan Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 69. Allergan Key News & Latest Developments
Table 70. Sun Pharmaceutical Industries Company Summary
Table 71. Sun Pharmaceutical Industries Ophthalmic Drugs Product Offerings
Table 72. Sun Pharmaceutical Industries Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 73. Sun Pharmaceutical Industries Key News & Latest Developments
Table 74. Actavis Generics Company Summary
Table 75. Actavis Generics Ophthalmic Drugs Product Offerings
Table 76. Actavis Generics Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 77. Actavis Generics Key News & Latest Developments
Table 78. Regeneron Pharmaceuticals Company Summary
Table 79. Regeneron Pharmaceuticals Ophthalmic Drugs Product Offerings
Table 80. Regeneron Pharmaceuticals Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 81. Regeneron Pharmaceuticals Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Ophthalmic Drugs Product Offerings
Table 84. Pfizer Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 85. Pfizer Key News & Latest Developments
Table 86. Johnson and Johnson Company Summary
Table 87. Johnson and Johnson Ophthalmic Drugs Product Offerings
Table 88. Johnson and Johnson Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 89. Johnson and Johnson Key News & Latest Developments
Table 90. Bausch and Lomb Company Summary
Table 91. Bausch and Lomb Ophthalmic Drugs Product Offerings
Table 92. Bausch and Lomb Ophthalmic Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2019-2024)
Table 93. Bausch and Lomb Key News & Latest Developments
Table 94. Ophthalmic Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2022-2024 (K MT)
Table 95. Global Ophthalmic Drugs Capacity Market Share of Key Manufacturers, 2022-2024
Table 96. Global Ophthalmic Drugs Production by Region, 2019-2024 (K MT)
Table 97. Global Ophthalmic Drugs Production by Region, 2025-2030 (K MT)
Table 98. Ophthalmic Drugs Market Opportunities & Trends in Global Market
Table 99. Ophthalmic Drugs Market Drivers in Global Market
Table 100. Ophthalmic Drugs Market Restraints in Global Market
Table 101. Ophthalmic Drugs Raw Materials
Table 102. Ophthalmic Drugs Raw Materials Suppliers in Global Market
Table 103. Typical Ophthalmic Drugs Downstream
Table 104. Ophthalmic Drugs Downstream Clients in Global Market
Table 105. Ophthalmic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ophthalmic Drugs Segment by Type in 2023
Figure 2. Ophthalmic Drugs Segment by Application in 2023
Figure 3. Global Ophthalmic Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Ophthalmic Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Ophthalmic Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Ophthalmic Drugs Sales in Global Market: 2019-2030 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Ophthalmic Drugs Revenue in 2023
Figure 9. By Type - Global Ophthalmic Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Ophthalmic Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Ophthalmic Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Ophthalmic Drugs Price (USD/MT), 2019-2030
Figure 13. By Application - Global Ophthalmic Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Ophthalmic Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Ophthalmic Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Ophthalmic Drugs Price (USD/MT), 2019-2030
Figure 17. By Region - Global Ophthalmic Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Ophthalmic Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Ophthalmic Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Ophthalmic Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Ophthalmic Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Ophthalmic Drugs Sales Market Share, 2019-2030
Figure 23. US Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Ophthalmic Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Ophthalmic Drugs Sales Market Share, 2019-2030
Figure 28. Germany Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Ophthalmic Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Ophthalmic Drugs Sales Market Share, 2019-2030
Figure 37. China Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Ophthalmic Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Ophthalmic Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Ophthalmic Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Ophthalmic Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Ophthalmic Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Ophthalmic Drugs Production Capacity (K MT), 2019-2030
Figure 53. The Percentage of Production Ophthalmic Drugs by Region, 2023 VS 2030
Figure 54. Ophthalmic Drugs Industry Value Chain
Figure 55. Marketing Channels
